Major histocompatibility complex (MHC) gene frequency in acquired dermal macular hyperpigmentation: a case control study
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17017 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Keshavamurthy Vinay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology & Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Hyperpigmentation, Gene Frequency, HLA-DQ beta-Chains. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Postgraduate Institute of Medical Education and Research, Chandigarh.
Abstract (Originalsprache)
Background
Human leukocyte antigen (HLA) allele frequencies have a known association with the pathogenesis of various autoimmune diseases.
Methods
We recruited 31 Indian patients of acquired dermal macular hyperpigmentation (ADMH) and 60 unrelated, age‐and‐gender‐matched healthy controls. After history and clinical examination, 5 ml of blood in EDTA vials was collected. These samples were subjected to DNA extraction and the expression of HLA A, B, C, DR, DQ‐A, and DQ‐B was studied.
Results
There was a predominance of females with a gender ratio of 23 : 8 and the most common phototype was Fitzpatrick type IV (83.9%). There was a significant association of HLA A*03:01 (OR: 5.8, CI: 1.7–17.0, P = 0.005), HLA B*07:02 (OR: 5.3, CI: 1.9–14.6, P = 0.003), HLA C*07:02 (OR: 4.3, CI: 1.8–9.6, P = 0.001), HLA DRB1*10:01 (OR: 7.6, CI: 1.7–38.00, P = 0.022), and HLA DRB1*15:02 (OR: 31.0, CI: 4.4–341.8, P < 0.001) with patients compared to controls, whereas HLA DQB*03:01 was less associated with patients compared to controls (OR: 0.2, CI: 0.0–0.6, P = 0.009).
Conclusion
Patients with ADMH are more likely to have the HLA A*03:01, HLA B 07*02, HLA C*07:02, HLA DRB1*10:01, HLA DRB1*15:02 and less likely to have the HLA DQB*03:01 allele. Larger cohort studies may thus be conducted studying these specific alleles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology & Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Keshavamurthy Vinay, Vignesh Narayan R
Förderung
- Postgraduate Institute of Medical Education and Research, Chandigarh
Zitieren
APA
Vinay, K., Kamat, D., Narayan R, V., Minz, R. W., Singh, J., Bishnoi, A., Chatterjee, D., Parsad, D., & Kumaran, M. S. (2024). Major histocompatibility complex (MHC) gene frequency in acquired dermal macular hyperpigmentation: a case control study. International Journal of Dermatology. https://doi.org/10.1111/ijd.17017
Vancouver
Vinay K, Kamat D, Narayan R V, Minz RW, Singh J, Bishnoi A, et al. Major histocompatibility complex (MHC) gene frequency in acquired dermal macular hyperpigmentation: a case control study. International Journal of Dermatology. 2024. doi:10.1111/ijd.17017
BibTeX
@article{Vinay2024,
author = {Vinay, Keshavamurthy and Kamat, Divya and Narayan R, Vignesh and Minz, Ranjana W and Singh, Jagdeep and Bishnoi, Anuradha and Chatterjee, Debajyoti and Parsad, Davinder and Kumaran, Muthu S},
title = {Major histocompatibility complex (MHC) gene frequency in acquired dermal macular hyperpigmentation: a case control study},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17017}
}
EUVIMED